[go: up one dir, main page]

EP3880690A4 - Peptides et compositions pharmaceutiques pour le traitement de maladies oculaires - Google Patents

Peptides et compositions pharmaceutiques pour le traitement de maladies oculaires Download PDF

Info

Publication number
EP3880690A4
EP3880690A4 EP19883897.1A EP19883897A EP3880690A4 EP 3880690 A4 EP3880690 A4 EP 3880690A4 EP 19883897 A EP19883897 A EP 19883897A EP 3880690 A4 EP3880690 A4 EP 3880690A4
Authority
EP
European Patent Office
Prior art keywords
peptides
pharmaceutical compositions
eye diseases
treating eye
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19883897.1A
Other languages
German (de)
English (en)
Other versions
EP3880690A2 (fr
Inventor
Taegon Baik
Jong-Yun Choi
Gyoung-Wook MIN
Chun Ho Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yuyu Pharma Inc
Original Assignee
Yuyu Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuyu Pharma Inc filed Critical Yuyu Pharma Inc
Publication of EP3880690A2 publication Critical patent/EP3880690A2/fr
Publication of EP3880690A4 publication Critical patent/EP3880690A4/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Immunology (AREA)
EP19883897.1A 2018-11-14 2019-11-14 Peptides et compositions pharmaceutiques pour le traitement de maladies oculaires Pending EP3880690A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862767180P 2018-11-14 2018-11-14
PCT/IB2019/001220 WO2020099925A2 (fr) 2018-11-14 2019-11-14 Peptides et compositions pharmaceutiques pour le traitement de maladies oculaires

Publications (2)

Publication Number Publication Date
EP3880690A2 EP3880690A2 (fr) 2021-09-22
EP3880690A4 true EP3880690A4 (fr) 2023-09-13

Family

ID=70732068

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19883897.1A Pending EP3880690A4 (fr) 2018-11-14 2019-11-14 Peptides et compositions pharmaceutiques pour le traitement de maladies oculaires

Country Status (11)

Country Link
EP (1) EP3880690A4 (fr)
JP (1) JP7522732B2 (fr)
KR (1) KR20210087539A (fr)
CN (1) CN113474356B (fr)
AU (1) AU2019378162B2 (fr)
BR (1) BR112021009341A2 (fr)
CA (1) CA3119921A1 (fr)
MX (1) MX2021005077A (fr)
SG (1) SG11202104178TA (fr)
TW (1) TWI865470B (fr)
WO (1) WO2020099925A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110945012A (zh) 2017-05-17 2020-03-31 株式会社柳柳制药 新型肽和用于治疗眼病的包含所述新型肽作为活性药物成分的药物组合物
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
ES3012499T3 (en) 2019-05-21 2025-04-09 Eyebio Korea Peptide compound or pharmaceutically acceptable salt thereof
US20230146455A1 (en) * 2020-03-05 2023-05-11 Yuyu Pharma, Inc. Treatment of inflammatory diseases with peptides and pharmaceutical compositions
KR102662922B1 (ko) * 2022-05-31 2024-05-03 주식회사 세네릭스 신규의 d-아미노산 유도체 및 이를 포함하는 약학 조성물

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
WO2017175963A1 (fr) * 2016-04-08 2017-10-12 주식회사 아이바이오코리아 Peptide dérivé à partir de la matrice extracellulaire de chondrocytes
EP3329929A1 (fr) * 2015-07-30 2018-06-06 Inje University Industry-Academic Cooperation Foundation Composition pharmaceutique pour la prévention ou le traitement de la sécheresse oculaire
EP3643723A1 (fr) * 2017-05-17 2020-04-29 Yuyu Pharma, Inc. Nouveau peptide et composition pharmaceutique pour le traitement de maladies oculaires comprenant ledit nouveau peptide en tant que principe actif

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101795653B1 (ko) * 2016-05-19 2017-11-09 인제대학교 산학협력단 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
KR20180074928A (ko) * 2016-12-26 2018-07-04 주식회사 아이바이오코리아 건성안 예방 또는 치료용 동물 의약품 조성물

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
EP3329929A1 (fr) * 2015-07-30 2018-06-06 Inje University Industry-Academic Cooperation Foundation Composition pharmaceutique pour la prévention ou le traitement de la sécheresse oculaire
WO2017175963A1 (fr) * 2016-04-08 2017-10-12 주식회사 아이바이오코리아 Peptide dérivé à partir de la matrice extracellulaire de chondrocytes
EP3441081A1 (fr) * 2016-04-08 2019-02-13 Eyebio Korea Peptide dérivé à partir de la matrice extracellulaire de chondrocytes
EP3643723A1 (fr) * 2017-05-17 2020-04-29 Yuyu Pharma, Inc. Nouveau peptide et composition pharmaceutique pour le traitement de maladies oculaires comprenant ledit nouveau peptide en tant que principe actif

Also Published As

Publication number Publication date
TWI865470B (zh) 2024-12-11
WO2020099925A3 (fr) 2020-06-25
SG11202104178TA (en) 2021-05-28
BR112021009341A2 (pt) 2021-08-10
AU2019378162A1 (en) 2021-05-20
WO2020099925A2 (fr) 2020-05-22
CN113474356A (zh) 2021-10-01
TW202031675A (zh) 2020-09-01
JP7522732B2 (ja) 2024-07-25
JP2022507404A (ja) 2022-01-18
CA3119921A1 (fr) 2020-05-22
EP3880690A2 (fr) 2021-09-22
CN113474356B (zh) 2024-12-17
KR20210087539A (ko) 2021-07-12
AU2019378162B2 (en) 2025-01-30
MX2021005077A (es) 2021-08-11

Similar Documents

Publication Publication Date Title
IL276464A (en) Methods and preparations for administering therapeutic protein
EP3880690A4 (fr) Peptides et compositions pharmaceutiques pour le traitement de maladies oculaires
EP3238736A4 (fr) Peptide pour traiter des maladies oculaires et composition pour traiter des maladies oculaires comprenant celui-ci
IL284344A (en) Pharmaceutical preparations for the eyes and methods for the treatment of diseases of the surface of the eye
EP3934646A4 (fr) Compositions pharmaceutiques pour le traitement de maladies ou de troubles oculaires
IL276244A (en) A pharmaceutical preparation for the eyes, a method for its preparation and its application
SG11201912110YA (en) Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient
EP3192875A4 (fr) Composition pharmaceutique à libération prolongée destinée au traitement et à la prévention de maladies ophtalmiques
EP3723750A4 (fr) Médicaments et compositions à administrer par voie oculaire
EP3818081A4 (fr) Compositions et méthodes pour le traitement de maladies ou de troubles liés aux inflammasomes
EP3691654A4 (fr) Compositions pharmaceutiques opthalmiques et procédés pour le traitement de maladie de surface oculaire
EP3634438A4 (fr) Compositions pour le traitement de maladies rétiniennes et leurs procédés de production et d'utilisation
IL280952A (en) Methods and drug compounds for the treatment of ophthalmic diseases
EP3831365A4 (fr) Composition pharmaceutique pour prévenir ou traiter des maladies atopiques
EP3768095A4 (fr) Compositions et méthodes pour le traitement des maladies diarrhéiques
EP3265103A4 (fr) Compositions et méthodes de traitement de maladies oculaires
EP3993833A4 (fr) Compositions et méthodes de traitement de maladies oculaires
EP3672583A4 (fr) Compositions et méthodes pour traiter des maladies neurodégénératives
HK40061089B (zh) 用於治疗眼病的肽和药物组合物
EP3856210A4 (fr) Compositions de protéines de matrice extracellulaire et procédés de traitement de plaies
EP3823635A4 (fr) Cellules épithéliales cornéennes et leurs produits pour le traitement de maladies cornéennes
HK40042312A (en) Methods and compositions for therapeutic protein delivery
HK40074800A (en) Peptides and methods for treating diseases
HK40056006A (en) Methods and compositions for drugs to treat ophthalmic diseases
HK40053279A (en) Compositions and methods for treating nrp2-associated diseases

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210614

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230330

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/00 20060101ALI20230510BHEP

Ipc: A61P 27/02 20060101ALI20230510BHEP

Ipc: A61K 9/00 20060101ALI20230510BHEP

Ipc: C07K 7/06 20060101AFI20230510BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20230817

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/00 20060101ALI20230810BHEP

Ipc: A61P 27/02 20060101ALI20230810BHEP

Ipc: A61K 9/00 20060101ALI20230810BHEP

Ipc: C07K 7/06 20060101AFI20230810BHEP